India’s apex drugs regulator turns the screws on pharmaceutical-grade raw materials linked to syrup contamination risks

The drug regulator has said no batch of key syrup ingredients can leave a factory without a digital clearance. Drug makers back the tighter tracking, but worry that portal glitches could hold up production and supplies.